The Max Planck Florida Institute for Neuroscience Partners with MetaCell to Enhance Data Science Capabilities
The Max Planck Florida Institute for Neuroscience Partners with MetaCell to Enhance Data Science Capabilities
The Max Planck Florida Institute for Neuroscience (MPFI) is proud to announce a new institutional partnership with MetaCell, a leading software company specializing in life sciences. This collaboration is delivering on-demand data science services for analyzing complex data in collaboration with MPFI's researchers.
Jupiter, FL. August 16, 2024 – The Max Planck Florida Institute for Neuroscience (MPFI) is proud to announce a new institutional partnership with MetaCell, a leading software company specializing in life sciences. This collaboration is delivering on-demand data science services for analyzing complex data in collaboration with MPFI's researchers.
The partnership will help MPFI scientists streamline their data science processes, promoting innovation and collaboration. Dedicated to unlocking the mysteries of the brain and providing the foundation for tomorrow’s cures, MPFI conducts high-impact research at the forefront of neuroscience. With over a decade of experience in neuroscience-specific data science, MetaCell brings a wealth of expertise and a structured methodology to data analysis.
"We are thrilled to partner with MetaCell, whose deep expertise in computational neuroscience and data science will be invaluable to our research community," said Ryohei Yasuda, Ph.D., Scientific Director at MPFI. "Their systematic approach to data analysis is ensuring transparency and scalability across our organization, fostering internal knowledge sharing and enhancing our overall research capabilities."
One of the key benefits of this partnership is the agility and accessibility of data science support available to each lab within MPFI. Working at the leading edge of neuroscience, MPFI researchers study facets of neural circuit function that have yet to be explored, generating unique datasets that require sophisticated analysis tools tailored to their research questions. MetaCell's on-demand data science services, in combination with its structured framework, allow researchers to seamlessly utilize the comprehensive suite of tools available through the cloud-based system.
"We're so excited to be partnering with the talented researchers at Max Planck Florida Institute for Neuroscience and continue to contribute to groundbreaking neuroscience research," said Stephen Larson, CEO of MetaCell. "Our approach to providing expert data science help remotely has already empowered MPFI researchers to achieve their scientific goals."
For more information, visit MPFI and MetaCell.
Media Contact:
Max Planck Florida Institute for Neuroscience
Katie Edwards
Associate Vice President, Public Engagement
+1 (561) 679-7395
MetaCell
Paolo Lenotti
Head of Marketing & PR
+44 7450 948685
About MPFI:
The Max Planck Florida Institute for Neuroscience (MPFI) is a not-for-profit research organization and part of the world-renowned Max Planck Society, Germany’s most successful research organization with over 84 institutes worldwide. Since its establishment in 1948, 31 Nobel laureates have emerged from the ranks of its scientists. As its only North American institution, MPFI provides exceptional neuroscientists with the resources and technology to answer fundamental brain development and function questions. MPFI researchers employ a curiosity-driven approach to science to develop new technologies that make groundbreaking scientific discoveries possible. For more information, visit https://www.mpfi.org/.
About MetaCell:
MetaCell is a leader in developing innovative software solutions for the life sciences industry. It has over 13 years of experience collaborating with research organizations such as J&J, Pfizer, Biogen, Eisai, Natus, Yale, Stanford, UCL, the Allen Institute, CAMH, and the Chan Zuckerberg Initiative. The company's vision is to harness the power of technological advancements and pioneering software solutions in life science to realize a healthier future for all humanity. Committed to excellence, integrity, and partnership, MetaCell strives to be the preferred innovation partner for pharma, healthcare, biotech, medical devices, academia, and non-profit research organizations. By accelerating breakthroughs in research and treatment through their software solutions, MetaCell aims to improve health outcomes and make a meaningful difference in people's lives. For more information, visit https://www.metacell.us/.
MetaCell.us is owned and operated by MetaCell, LLC, LTD. MetaCell.us contains copyrighted and other proprietary information. Copyright on MetaCell.us (including but not limited to text, photographs, graphics, videos and software) is owned by MetaCell or its partners. No right, title or interest in any content of MetaCell.us is transferred or licensed to you as a result of your use of the website. Other than for private use, you may not download or copy, store in any medium (including any other website), distribute, transmit, re-transmit, modify, show in public or make commercial or business use of any part of MetaCell.us without the prior written consent of MetaCell. By accessing MetaCell.us you agree not to use the content for any illegal or improper purpose. No part of MetaCell.us may be reproduced or distributed in any material form or medium without the permission of MetaCell.